Reporting person on SEC Form 4

Alexander Hardy

Alexander Hardy is Chief Executive Officer at BioMarin Pharmaceutical. OQRO lists 6 transactions filed with the SEC under this name, the latest on Mar 19, 2026, each linked to the official Form 4.

Chief Executive Officer

Disclosures on record

6

Companies involved

1

Disclosure history

BioMarin PharmaceuticalBMRN
6 disclosures · Dec 2025 – Mar 2026
- Mar 17, 20264,252disclosed Mar 19
  Details Official record
- Mar 16, 202662Kdisclosed Mar 18
  Details Official record

Mar 16, 202689Kdisclosed Mar 18

Details Official record

Mar 13, 20262,941disclosed Mar 18

Details Official record

Apr 30, 2025375disclosed Dec 2

Details Official record

Dec 1, 202517Kdisclosed Dec 2

Details Official record

All activity in BioMarin Pharmaceutical